IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Catalys Pacific, LLC

Q1 2025 Holdings

Filed 2025-05-14 | 2 holdings | $148.7M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗

Amended (2025-08-13) | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Mineralys Therapeutics, Inc.(MLYS)ACOM603170101$141.4M8,903,83895.1%
Phathom Pharmaceuticals, Inc.(PHAT)COM71722W107$7.3M1,167,1144.9%